143 related articles for article (PubMed ID: 7579497)
1. Nonattendance in the Stockholm mammography screening trial: relative mortality and reasons for nonattendance.
Lidbrink E; Frisell J; Brandberg Y; Rosendahl I; Rutqvist LE
Breast Cancer Res Treat; 1995 Sep; 35(3):267-75. PubMed ID: 7579497
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting participation in mammography screening.
McNoe B; Richardson AK; Elwood JM
N Z Med J; 1996 Sep; 109(1030):359-61. PubMed ID: 8890861
[TBL] [Abstract][Full Text] [Related]
3. Attitudes, beliefs, and knowledge as predictors of nonattendance in a Swedish population-based mammography screening program.
Lagerlund M; Hedin A; Sparén P; Thurfjell E; Lambe M
Prev Med; 2000 Oct; 31(4):417-28. PubMed ID: 11006068
[TBL] [Abstract][Full Text] [Related]
4. The Stockholm breast cancer screening trial--5-year results and stage at discovery.
Frisell J; Eklund G; Hellström L; Glas U; Somell A
Breast Cancer Res Treat; 1989 Jan; 13(1):79-87. PubMed ID: 2706329
[TBL] [Abstract][Full Text] [Related]
5. Nonattendance in mammographic screening: a study of intraurban differences in Malmö, Sweden, 1990-1994.
Matson S; Andersson I; Berglund G; Janzon L; Manjer J
Cancer Detect Prev; 2001; 25(2):132-7. PubMed ID: 11341348
[TBL] [Abstract][Full Text] [Related]
6. Cancer anxiety and attitudes toward mammography among screening attenders, nonattenders, and women never invited.
Gram IT; Slenker SE
Am J Public Health; 1992 Feb; 82(2):249-51. PubMed ID: 1739156
[TBL] [Abstract][Full Text] [Related]
7. Interval cancer and survival in a randomized breast cancer screening trial in Stockholm.
Frisell J; von Rosen A; Wiege M; Nilsson B; Goldman S
Breast Cancer Res Treat; 1992; 24(1):11-6. PubMed ID: 1463867
[TBL] [Abstract][Full Text] [Related]
8. Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma.
Zackrisson S; Andersson I; Manjer J; Janzon L
Int J Cancer; 2004 Feb; 108(5):754-60. PubMed ID: 14696103
[TBL] [Abstract][Full Text] [Related]
9. Screening for breast cancer in women aged under 50: mode of detection, incidence, fatality, and histology.
Tabar L; Fagerberg G; Chen HH; Duffy SW; Gad A
J Med Screen; 1995; 2(2):94-8. PubMed ID: 7497163
[TBL] [Abstract][Full Text] [Related]
10. Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.
Chuang SL; Chen SL; Yu CP; Chang KJ; Yen AM; Chiu SY; Fann JC; Tabár L; Stephen DW; Smith RA; Chen HH
APMIS; 2014 Aug; 122(8):699-707. PubMed ID: 25046200
[TBL] [Abstract][Full Text] [Related]
11. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.
Duffy SW; Tabár L; Chen HH; Holmqvist M; Yen MF; Abdsalah S; Epstein B; Frodis E; Ljungberg E; Hedborg-Melander C; Sundbom A; Tholin M; Wiege M; Akerlund A; Wu HM; Tung TS; Chiu YH; Chiu CP; Huang CC; Smith RA; Rosén M; Stenbeck M; Holmberg L
Cancer; 2002 Aug; 95(3):458-69. PubMed ID: 12209737
[TBL] [Abstract][Full Text] [Related]
12. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
[TBL] [Abstract][Full Text] [Related]
13. Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification.
Burhenne HJ; Burhenne LW; Goldberg F; Hislop TG; Worth AJ; Rebbeck PM; Kan L
AJR Am J Roentgenol; 1994 May; 162(5):1067-71; discussion 1072-5. PubMed ID: 8165983
[TBL] [Abstract][Full Text] [Related]
14. The Stockholm Mammographic Screening Trial: Risks and benefits in age group 40-49 years.
Frisell J; Lidbrink E
J Natl Cancer Inst Monogr; 1997; (22):49-51. PubMed ID: 9709275
[TBL] [Abstract][Full Text] [Related]
15. Followup after 11 years--update of mortality results in the Stockholm mammographic screening trial.
Frisell J; Lidbrink E; Hellström L; Rutqvist LE
Breast Cancer Res Treat; 1997 Sep; 45(3):263-70. PubMed ID: 9386870
[TBL] [Abstract][Full Text] [Related]
16. Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malmö, Stockholm, and Göteborg.
Nyström L; Bjurstam N; Jonsson H; Zackrisson S; Frisell J
J Med Screen; 2017 Mar; 24(1):34-42. PubMed ID: 27306511
[TBL] [Abstract][Full Text] [Related]
17. The Gothenburg Breast Cancer Screening Trial: preliminary results on breast cancer mortality for women aged 39-49.
Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Erikson O; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säwe-Söderberg J
J Natl Cancer Inst Monogr; 1997; (22):53-5. PubMed ID: 9709276
[TBL] [Abstract][Full Text] [Related]
18. [Assessment of mammography screening and its introduction in Germany in the Statutory Early Diagnosis Program].
von Fournier D
Zentralbl Gynakol; 1999; 121(3):159-65. PubMed ID: 10209861
[TBL] [Abstract][Full Text] [Related]
19. Clinical problems in relation to breast cancer screening with mammography. A preliminary report.
Lundström B; Fagerberg G
Acta Chir Scand Suppl; 1984; 519():61-3. PubMed ID: 6595925
[TBL] [Abstract][Full Text] [Related]
20. The general mammography screening program in Stockholm. Organisation and first-round results.
Lidbrink EK; Törnberg SA; Azavedo EM; Frisell JO; Hjalmar ML; Leifland KS; Sahlstedt TB; Skoog L
Acta Oncol; 1994; 33(4):353-8. PubMed ID: 8018365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
